BioCentury
ARTICLE | Company News

Morphotek, Eisai deal

March 26, 2007 7:00 AM UTC

Eisai bolstered its oncology portfolio last September by acquiring the cancer product line of Ligand Pharmaceuticals Inc. (LGND, San Diego, Calif.) (see BioCentury, Sept. 11, 2006). Eisai also has E...